Holen Sie sich die Stockscreener-App
87.10
0.85%
-0.75
Vorhandelsmarkt:
87.48
0.38
+0.44%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$87.85
Offen:
$87.2
24-Stunden-Volumen:
7.10M
Relative Volume:
0.95
Marktkapitalisierung:
$111.40B
Einnahmen:
$407.94B
Nettoeinkommen (Verlust:
$2.90B
KGV:
38.25
EPS:
2.2771
Netto-Cashflow:
$7.39B
1W Leistung:
+0.00%
1M Leistung:
-6.40%
6M Leistung:
+24.29%
1J Leistung:
+15.26%
1-Tages-Spanne:
$86.36
$87.56
1-Wochen-Bereich:
$84.50
$90.02
52-Wochen-Spanne:
$69.51
$110.68
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
87.10 | 113.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
UNH
Unitedhealth Group Inc
|
374.94 | 338.03B | 450.13B | 14.91B | 23.62B | 15.55 |
ELV
Elevance Health Inc
|
392.73 | 85.90B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
275.26 | 71.88B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
386.87 | 47.78B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-12 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-08-18 | Hochstufung | UBS | Neutral → Buy |
| 2025-08-14 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
CVS Health stock at USD 89.13 on September 25, 2026 - AD HOC NEWS
CVS Health Corp (CVS) Shares Surge 4.8% -- What GF Score of 81 T - GuruFocus
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
Why is CVS Health stock rallying today? - Investing.com
Why is CVS Health stock rallying today? By Investing.com - Investing.com Canada
CVS rises as investors revisit stronger guidance and fading Omnicare overhang - Quiver Quantitative
CVS Health Corp Stock (CVS) Moved Up by 3.65% on Sep 25: What Signal Does It Send? - TradingKey
CVS Health stock trades at USD 85.21 as Q2 revenue rises 7.3 percent - AD HOC NEWS
CVS Health Strengthens Energy Resilience To Support Patient Care - ACCESS Newswire
CVS Health stock heads into the open after an 1.2 percent drop - ad-hoc-news.de
CVS Looks 7.6% Overvalued on GF Value™ as Dividend Sustainabilit - GuruFocus
What Should CVS Stock Investors Be Watching Now? - Yahoo Finance
After 30 years, a Hepatitis C treatment that finally worked - CVS Health
Aetna expands cancer treatment prior authorization bundles - Investing.com
CVS Health; Criteo Agree to Pay $20.5 Million to Resolve Website Tracking Litigation - The HIPAA Journal
Aetna Expands Bundled Oncology Prior Authorizations, Easing Provider Burden and Accelerating Member Access to Care - finance.yahoo.com
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
CVS online shoppers could get cash from $20.5M settlement - The Clarion-Ledger
QRG Capital Management Inc. Raises Stock Holdings in CVS Health Corporation $CVS - MarketBeat
Envestnet Asset Management Inc. Boosts Stake in CVS Health Corporation $CVS - MarketBeat
CVS Health stock slips 1.4 percent ahead of the open - AD HOC NEWS
CVS Health stock falls 2.93 percent at the close - AD HOC NEWS
CVS Health Corp. stock outperforms competitors despite losses on the day - MarketWatch
As measles cases rise in Tennessee, CVS Health® reminds residents that vaccines are available statewide - marketscreener.com
Measles can infect up to 9 in 10 unprotected people nearby. CVS offers Tennessee shots. - Stock Titan
CVS Health Launches National "Wear Your HeART" Bandage Art Contest - Yahoo Finance
CVS Health strengthens energy resilience to support patient care - CVS Health
Here’s What Strengthened CVS Health (CVS) in Q2 - Yahoo Finance
CVS settles data privacy lawsuit for $20.5M: See if you qualify for a payout - WCNC
Why is CVS Health (NYSE:CVS) in focus amid today’s value stocks discussion? - Kalkine Media
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
CVS Health stock holds near USD 87.73 as earnings beat estimates - AD HOC NEWS
CVS agrees to $20.5M class action settlement: Here’s who qualifies for a payment - Yahoo Finance
CVS Health stock closes lower at the close - AD HOC NEWS
Anyone who has used CVS’ website is owed money. Here’s how to get a payment - woodtv.com
State Street Corp Boosts Stake in CVS Health Corporation $CVS - MarketBeat
Value-based care is hard, but it’s worth getting right - CVS Health
UBS reiterates CVS Health stock rating citing no new surprises - Investing.com
CVS vs. CAH: Which Healthcare Services Stock Is the Better Pick Now? - Yahoo Finance
CVS Health Corp (CVS) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
CVS Health stock trades at USD 87.60 as guidance rises - AD HOC NEWS
CVS Health (NYSE:CVS) Faces Healthcare Execution As Defensive Sectors Draw - Kalkine Media
CVS Health’s Yield Touched 3% as the Stock Slid. Is the Payout a Bargain or a Warning? - finance.yahoo.com
CVS Health (CVS) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
CVS Health Corp. stock underperforms Monday when compared to competitors - MarketWatch
CVS, health giants move to subpoena Tennessee lawmakers' private files - The Business Journals
Judge approves bankruptcy plan for CVS’ Omnicare - Modern Healthcare
Here's What Might Affect CVS Health's 2026 Financial Outlook - Barchart.com
CVS Health Corp stock gains analyst support as oncology initiative advances - AD HOC NEWS
Top 3 Health Care Stocks That May Rocket Higher In September - benzinga.com
Judge approves CVS unit Omnicare’s bankruptcy plan - Yahoo Finance
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
1.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):